866-997-4948(US-Canada Toll Free)

Global and China Urinary System Drugs Industry Professional Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

This report splits Urinary System Drugs market by Loop diuretics, by Thiazide diuretic, by Thiazide-like diuretics, by potassium-sparing diuretics, by Vasopressin receptor antagonist, which shares the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details.

This report focus Global and China market, coving details as following:
Key Players
AMRI India Pvt. Ltd.
Novartis Pharma Schweiz AG
Merck Sharp & Dohme B.V.
Sanofi Clir SNC
Ipca Laboratories Limited
Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A.
Otsuka Pharmaceutical Co.,Ltd.
Roquette Freres

Key Regions
Asia Pacific
China
First-tier Cities
Second-tier Cities
Third-tier Cities
Others
Japan
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

Key Product Type
Urinary System Drugs Market, by Loop diuretics
Furosemide
Bumetanide
Bumetanide
Ethacrynic Acid
Etozolin
Muzolimine
Piretanide
Ticrynafen
Torasemide
Urinary System Drugs Market, by Thiazide diuretic
Hydrochlorothiazide
Bendrofluazide
Hdyroflumethiazide
Polythiazide
Trichlormethiazide
Cyclopenthiazide
Methyclothiazide
Cyclothiazide
Mebutizide
Urinary System Drugs Market, by Thiazide-like diuretics
Quinethazone
Clopamide
Chlorthalidone
Mefruside
Clofenamide
Metolazone
Meticrane
Xipamide
Indapamide
Clorexolone
Fenquizone
Urinary System Drugs Market, by potassium-sparing diuretics
Amiloride
Triamterene
Spironolactone
Eplerenone
Canrenoate Potassium
Canrenone
Urinary System Drugs Market, by Vasopressin receptor antagoni
Conivaptan
Mozavaptan
Tolvaptan
Demeclocycline
Main Applications
Urology Surgery
department of nephropathy
Liver disease division
Hospital
Clinic

Key Consumers (End User)
Urology Surgery
department of nephropathy
Liver disease division
Hospital
Clinic


Table of Contents

Global and China Urinary System Drugs Industry Professional Market Report 2017
Chapter One Global and China Urinary System Drugs Market Overview
1.1 China Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
1.2 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017
1.3 Global and China Urinary System Drugs, by Loop diuretics 2012-2017
1.3.1 China Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
1.3.2 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017
1.3.3 China Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
1.3.4 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017
1.3.5 China Urinary System Drugs Price by Loop diuretics 2012-2017
1.3.6 Global Urinary System Drugs Price by Loop diuretics 2012-2017
1.3.7 Furosemide
1.3.8 Bumetanide
1.3.9 Bumetanide
1.3.10 Ethacrynic Acid
1.3.11 Etozolin
1.4 Global and China Urinary System Drugs, by Thiazide diuretic 2012-2017
1.4.1 China Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
1.4.2 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017
1.4.3 China Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
1.4.4 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017
1.4.5 China Urinary System Drugs Price by Thiazide diuretic 2012-2017
1.4.6 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017
1.4.7 Hydrochlorothiazide
1.4.8 Bendrofluazide
1.4.9 Hdyroflumethiazide
1.4.10 Polythiazide
1.4.11 Trichlormethiazide
1.5 Global and China Urinary System Drugs, by Thiazide-like diuretics 2012-2017
1.5.1 China Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
1.5.2 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017
1.5.3 China Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
1.5.4 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017
1.5.5 China Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
1.5.6 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017
1.5.7 Quinethazone
1.5.8 Clopamide
1.5.9 Chlorthalidone
1.5.10 Mefruside
1.5.11 Clofenamide
1.6 Global and China Urinary System Drugs, by potassium-sparing diuretics 2012-2017
1.6.1 China Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
1.6.2 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017
1.6.3 China Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
1.6.4 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017
1.6.5 China Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
1.6.6 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017
1.6.7 Amiloride
1.6.8 Triamterene
1.6.9 Spironolactone
1.6.10 Eplerenone
1.6.11 Canrenoate Potassium
1.7 Global and China Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017
1.7.1 China Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
1.7.2 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017
1.7.3 China Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
1.7.4 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017
1.7.5 China Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
1.7.6 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017
1.7.7 Conivaptan
1.7.8 Mozavaptan
1.7.9 Tolvaptan
1.7.10 Demeclocycline

Chapter Two China Urinary System Drugs Market by Regions 2012-2017
2.1 China Urinary System Drugs Sales Market Share by Regions 2012-2017
2.2 China Urinary System Drugs Revenue Market Share by Regions 2012-2017
2.3 China Urinary System Drugs Price by Regions 2012-2017
2.4 First-tier Cities
2.5 Second-tier Cities
2.6 Third-tier Cities
2.7 Other Regions

Chapter Three Global Urinary System Drugs Market by Regions 2012-2017
3.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017
3.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017
3.3 Global Urinary System Drugs Price by Regions 2012-2017
3.4 Asia Pacific
3.4.1 China
3.4.2 Japan
3.4.3 Korea
3.4.4 India
3.4.5 Others
3.5 Europe
3.5.1 Germany
3.5.2 United Kingdom
3.5.3 France
3.5.4 Italy
3.5.5 Russia
3.5.6 Others
3.6 North America
3.6.1 United States
3.6.2 Canada
3.7 Latin America
3.7.1 Brazil
3.7.2 Mexico
3.7.3 Others
3.8 Southeast Asia
3.8.1 Singapore
3.8.2 Malaysia
3.8.3 Vietnam
3.8.4 Myanmar
3.8.5 Thailand
3.8.6 Indonesia
3.8.7 Philippines
3.8.8 Others
3.9 Middle East & Africa
3.9.1 Saudi Arabia
3.9.2 Iran
3.9.3 UAE
3.9.4 Turkey
3.9.5 Israel
3.9.6 Egypt
3.9.7 South Africa
3.9.8 Others

Chapter Four Urinary System Drugs by Players 2012-2017
4.1 China Urinary System Drugs Sales Volume Market Share by Players 2012-2017
4.2 China Urinary System Drugs Revenue Share by Players 2012-2017
4.3 China Top Players Urinary System Drugs Key Product Model and Market Performance
4.4 China Top Players Urinary System Drugs Key Target Consumers and Market Performance

Chapter Five Top Players Profile
5.1 AMRI India Pvt. Ltd.
5.1.1 AMRI India Pvt. Ltd. Company Details and Competitors
5.1.2 AMRI India Pvt. Ltd. Key Urinary System Drugs Models and Performance
5.1.3 AMRI India Pvt. Ltd. Urinary System Drugs Business SWOT Analysis and Forecast
5.1.4 AMRI India Pvt. Ltd. Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.2 Novartis Pharma Schweiz AG
5.2.1 Novartis Pharma Schweiz AG Company Details and Competitors
5.2.2 Novartis Pharma Schweiz AG Key Urinary System Drugs Models and Performance
5.2.3 Novartis Pharma Schweiz AG Urinary System Drugs Business SWOT Analysis and Forecast
5.2.4 Novartis Pharma Schweiz AG Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.3 Merck Sharp & Dohme B.V.
5.3.1 Merck Sharp & Dohme B.V. Company Details and Competitors
5.3.2 Merck Sharp & Dohme B.V. Key Urinary System Drugs Models and Performance
5.3.3 Merck Sharp & Dohme B.V. Urinary System Drugs Business SWOT Analysis and Forecast
5.3.4 Merck Sharp & Dohme B.V. Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.4 Sanofi Clir SNC
5.4.1 Sanofi Clir SNC Company Details and Competitors
5.4.2 Sanofi Clir SNC Key Urinary System Drugs Models and Performance
5.4.3 Sanofi Clir SNC Urinary System Drugs Business SWOT Analysis and Forecast
5.4.4 Sanofi Clir SNC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.5 Ipca Laboratories Limited
5.5.1 Ipca Laboratories Limited Company Details and Competitors
5.5.2 Ipca Laboratories Limited Key Urinary System Drugs Models and Performance
5.5.3 Ipca Laboratories Limited Urinary System Drugs Business SWOT Analysis and Forecast
5.5.4 Ipca Laboratories Limited Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.6 Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A.
5.6.1 Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Company Details and Competitors
5.6.2 Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Key Urinary System Drugs Models and Performance
5.6.3 Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Business SWOT Analysis and Forecast
5.6.4 Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.7 Otsuka Pharmaceutical Co.,Ltd.
5.7.1 Otsuka Pharmaceutical Co.,Ltd. Company Details and Competitors
5.7.2 Otsuka Pharmaceutical Co.,Ltd. Key Urinary System Drugs Models and Performance
5.7.3 Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Business SWOT Analysis and Forecast
5.7.4 Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin
5.8 Roquette Freres
5.8.1 Roquette Freres Company Details and Competitors
5.8.2 Roquette Freres Key Urinary System Drugs Models and Performance
5.8.3 Roquette Freres Urinary System Drugs Business SWOT Analysis and Forecast
5.8.4 Roquette Freres Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

Chapter Six Urinary System Drugs by Consumer 2012-2017
6.1 China Urinary System Drugs Sales Market Share by Consumer 2012-2017
6.2 Global Urinary System Drugs Sales Market Share by Consumer 2012-2017
6.3 Urology Surgery
6.4 department of nephropathy
6.5 Liver disease division
6.6 Hospital
6.7 Clinic
6.8 Consuming Habit and Preference

Chapter Seven Global and China Urinary System Drugs Market Size (Sales and Revenue) Forecast (2017-2022)
7.1 Global and China Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
7.1.1 China Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
7.1.2 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
7.2 Global and China Urinary System Drugs Sales () Forecast by Type (2017-2022)
7.2.1 by by Loop diuretics
7.2.2 by by Thiazide diuretic
7.2.3 by Thiazide-like diuretics
7.2.4 by potassium-sparing diuretics
7.2.5 by Vasopressin receptor antagonis
7.3 Global and China Urinary System Drugs Sales () Forecast by Application (2017-2022)
7.4 Global and China Urinary System Drugs Sales () Forecast by Regions (2017-2022)

Chapter Eight Industry Chain and Supply Chain
8.1 Urinary System Drugs Industry Chain Structure
8.1.1 R&D
8.1.2 Raw Materials (Components)
8.1.3 Manufacturing Plants
8.1.4 Regional Trading (Import Export and Local Sales)
8.1.5 Online Sales Channel
8.1.6 Offline Channel
8.1.7 End Users
8.2 Urinary System Drugs Manufacturing
8.2.1 Key Components
8.2.2 Assembly Manufacturing
8.3 Consumer Preference
8.4 Behavioral Habits
8.5 Marketing Environment

Chapter Nine Development Trend and Research Conclusion
9.1 Development Trend
9.2 Research Conclusion

Chapter Ten Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Disclaimer


List of Table

List of Tables and Figures

Table China Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure China Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table China Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016
Table China Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016
Table China Urinary System Drugs Price () by Loop diuretics (2012-2017)
Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)
Figure China Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table China Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016
Table China Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016
Table China Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)
Figure China Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table China Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016
Table China Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016
Table China Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)
Figure China Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table China Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure China Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016
Table China Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table China Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016
Table China Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)
Figure China Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table China Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016
Table China Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016
Table China Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)
Figure China Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales () by Regions (2012-2017)
Table China Urinary System Drugs Sales Share by Regions (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Regions in 2016
Figure China Urinary System Drugs Sales Market Share by Regions in 2017
Table China Urinary System Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Regions (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Regions in 2016
Figure China Urinary System Drugs Revenue Market Share by Regions in 2017
Table China Urinary System Drugs Price () by Regions (2012-2017)
Table Global Urinary System Drugs Sales () by Regions (2012-2017)
Table Global Urinary System Drugs Sales Share by Regions (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Regions in 2016
Figure Global Urinary System Drugs Sales Market Share by Regions in 2017
Table Global Urinary System Drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016
Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017
Table Global Urinary System Drugs Price () by Regions (2012-2017)
Table Asia Pacific Urinary System Drugs Sales () by Regions (2012-2017)
Table Asia Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Asia Pacific Urinary System Drugs Business Strategy, Channel and Performance List
Figure Asia Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Europe Urinary System Drugs Sales () by Regions (2012-2017)
Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Europe Urinary System Drugs Business Strategy, Channel and Performance List
Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table North America Urinary System Drugs Sales () by Regions (2012-2017)
Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of North America Urinary System Drugs Business Strategy, Channel and Performance List
Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)
Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Latin America Urinary System Drugs Business Strategy, Channel and Performance List
Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Southeast Asia Urinary System Drugs Sales () by Regions (2012-2017)
Table Southeast Asia Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Southeast Asia Urinary System Drugs Business Strategy, Channel and Performance List
Figure Southeast Asia Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table Middle East & Africa Urinary System Drugs Sales () by Regions (2012-2017)
Table Middle East & Africa Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)
Table Top Companies of Middle East & Africa Urinary System Drugs Business Strategy, Channel and Performance List
Figure Middle East & Africa Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure South Africa Urinary System Drugs Sales () and Growth Rate (2012-2017)
Table China Urinary System Drugs Sales Volume () by Key Players (2012-2017)
Table China Urinary System Drugs Sales Volume Market Share by Key Players (2012-2017)
Figure China Urinary System Drugs Sales Volume Market Share by Key Players 2016
Figure China Urinary System Drugs Sales Volume Market Share by Key Players 2017
Table China Urinary System Drugs Revenue (Million USD) by Key Players (2012-2017)
Table China Urinary System Drugs Revenue Market Share by Key Players (2012-2017)
Figure China Urinary System Drugs Revenue Market Share by Key Players 2016
Figure China Urinary System Drugs Revenue Market Share by Key Players 2017
Table China Top Brands Key Product Model and Market Performance
Table China Top Brands Key Target Consumers and Market Performance
Table AMRI India Pvt. Ltd. Company Details and Competitors
Table AMRI India Pvt. Ltd. Key Urinary System Drugs Models and Performance
Table AMRI India Pvt. Ltd. Urinary System Drugs Business SWOT Analysis and Forecast
Table AMRI India Pvt. Ltd. Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure AMRI India Pvt. Ltd. Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure AMRI India Pvt. Ltd. Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure AMRI India Pvt. Ltd. Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure AMRI India Pvt. Ltd. Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Novartis Pharma Schweiz AG Company Details and Competitors
Table Novartis Pharma Schweiz AG Key Urinary System Drugs Models and Performance
Table Novartis Pharma Schweiz AG Urinary System Drugs Business SWOT Analysis and Forecast
Table Novartis Pharma Schweiz AG Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Novartis Pharma Schweiz AG Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Novartis Pharma Schweiz AG Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Novartis Pharma Schweiz AG Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Novartis Pharma Schweiz AG Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Merck Sharp & Dohme B.V. Company Details and Competitors
Table Merck Sharp & Dohme B.V. Key Urinary System Drugs Models and Performance
Table Merck Sharp & Dohme B.V. Urinary System Drugs Business SWOT Analysis and Forecast
Table Merck Sharp & Dohme B.V. Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Merck Sharp & Dohme B.V. Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Merck Sharp & Dohme B.V. Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Merck Sharp & Dohme B.V. Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Merck Sharp & Dohme B.V. Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Sanofi Clir SNC Company Details and Competitors
Table Sanofi Clir SNC Key Urinary System Drugs Models and Performance
Table Sanofi Clir SNC Urinary System Drugs Business SWOT Analysis and Forecast
Table Sanofi Clir SNC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Sanofi Clir SNC Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Sanofi Clir SNC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Sanofi Clir SNC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Sanofi Clir SNC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Ipca Laboratories Limited Company Details and Competitors
Table Ipca Laboratories Limited Key Urinary System Drugs Models and Performance
Table Ipca Laboratories Limited Urinary System Drugs Business SWOT Analysis and Forecast
Table Ipca Laboratories Limited Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Ipca Laboratories Limited Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Ipca Laboratories Limited Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Ipca Laboratories Limited Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Ipca Laboratories Limited Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Company Details and Competitors
Table Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Key Urinary System Drugs Models and Performance
Table Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Business SWOT Analysis and Forecast
Table Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Laboratorio Italiano Biochimico Farmaceutico LISAPHARMA S.p.A. Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Otsuka Pharmaceutical Co.,Ltd. Company Details and Competitors
Table Otsuka Pharmaceutical Co.,Ltd. Key Urinary System Drugs Models and Performance
Table Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Business SWOT Analysis and Forecast
Table Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Otsuka Pharmaceutical Co.,Ltd. Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table Roquette Freres Company Details and Competitors
Table Roquette Freres Key Urinary System Drugs Models and Performance
Table Roquette Freres Urinary System Drugs Business SWOT Analysis and Forecast
Table Roquette Freres Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Figure Roquette Freres Urinary System Drugs Sales() and Growth Rate (%)(2012-2017)
Figure Roquette Freres Urinary System Drugs Sales Market Share (%) in Global (2012-2017)
Figure Roquette Freres Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
Figure Roquette Freres Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)
Table China Urinary System Drugs Sales () by Consumer (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure China Urinary System Drugs Sales Market Share by Consumer in 2016
Table Global Urinary System Drugs Sales () by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer (2012-2017)
Figure Global Urinary System Drugs Sales Market Share by Consumer in 2016
Figure China Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)
Figure China Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure China Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Urinary System Drugs Price () Trend Forecast (2017-2022)
Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)
Table China Urinary System Drugs Sales () Forecast by Type (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure China Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure Global Urinary System Drugs Sales () Forecast by Type (2017-2022)
Figure China Urinary System Drugs Sales Volume Market Share Forecast by Type in 2017
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Type in 2017
Table China Urinary System Drugs Sales () Forecast by Application (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)
Figure China Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Urinary System Drugs Sales Volume Market Share Forecast by Application in 2017
Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application in 2017
Table China Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table China Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)
Figure China Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *